nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—CYP24A1—bronchus—esophageal cancer	0.02	0.128	CbGeAlD
Calcitriol—Apprehension—Cisplatin—esophageal cancer	0.0195	0.0832	CcSEcCtD
Calcitriol—GC—digestive system—esophageal cancer	0.0185	0.118	CbGeAlD
Calcitriol—CYP24A1—trachea—esophageal cancer	0.018	0.115	CbGeAlD
Calcitriol—VDR—neck—esophageal cancer	0.0164	0.105	CbGeAlD
Calcitriol—CYP24A1—digestive system—esophageal cancer	0.0154	0.0986	CbGeAlD
Calcitriol—Renal failure chronic—Cisplatin—esophageal cancer	0.0139	0.0593	CcSEcCtD
Calcitriol—CYP24A1—lung—esophageal cancer	0.0129	0.0824	CbGeAlD
Calcitriol—Haemolysis—Cisplatin—esophageal cancer	0.0117	0.0502	CcSEcCtD
Calcitriol—VDR—epithelium—esophageal cancer	0.0112	0.0714	CbGeAlD
Calcitriol—VDR—bronchus—esophageal cancer	0.011	0.0703	CbGeAlD
Calcitriol—VDR—trachea—esophageal cancer	0.00989	0.0631	CbGeAlD
Calcitriol—Sensory disturbance—Capecitabine—esophageal cancer	0.00888	0.0379	CcSEcCtD
Calcitriol—VDR—digestive system—esophageal cancer	0.0085	0.0543	CbGeAlD
Calcitriol—VDR—lung—esophageal cancer	0.0071	0.0454	CbGeAlD
Calcitriol—Taste metallic—Methotrexate—esophageal cancer	0.00645	0.0275	CcSEcCtD
Calcitriol—Serum creatinine increased—Cisplatin—esophageal cancer	0.00607	0.0259	CcSEcCtD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00599	0.00984	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00573	0.00941	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00566	0.00929	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—SNAI2—esophageal cancer	0.00531	0.00872	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—esophageal cancer	0.00506	0.00831	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00502	0.00824	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00494	0.00811	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—esophageal cancer	0.00493	0.00809	CbGpPWpGaD
Calcitriol—VDR—lymph node—esophageal cancer	0.00486	0.031	CbGeAlD
Calcitriol—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00466	0.00766	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00465	0.00763	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00462	0.00758	CbGpPWpGaD
Calcitriol—Rhinorrhoea—Cisplatin—esophageal cancer	0.00461	0.0197	CcSEcCtD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00456	0.00748	CbGpPWpGaD
Calcitriol—Serum creatinine increased—Capecitabine—esophageal cancer	0.00448	0.0191	CcSEcCtD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00441	0.00723	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00434	0.00713	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00429	0.00704	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—ADH7—esophageal cancer	0.00425	0.00698	CbGpPWpGaD
Calcitriol—Hypercalcaemia—Capecitabine—esophageal cancer	0.00396	0.0169	CcSEcCtD
Calcitriol—Pain—Carboplatin—esophageal cancer	0.00389	0.0166	CcSEcCtD
Calcitriol—Blister—Capecitabine—esophageal cancer	0.00382	0.0163	CcSEcCtD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00375	0.00615	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TNFRSF10A—esophageal cancer	0.00374	0.00614	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—ADH1B—esophageal cancer	0.00373	0.00612	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—CREBBP—esophageal cancer	0.00371	0.00609	CbGpPWpGaD
Calcitriol—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00369	0.00605	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00359	0.0059	CbGpPWpGaD
Calcitriol—Body temperature increased—Carboplatin—esophageal cancer	0.00359	0.0153	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—esophageal cancer	0.00359	0.00589	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—ABL1—esophageal cancer	0.00358	0.00588	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00352	0.00578	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—CYP26A1—esophageal cancer	0.00346	0.00569	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00342	0.00561	CbGpPWpGaD
Calcitriol—Rhinorrhoea—Capecitabine—esophageal cancer	0.0034	0.0145	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—BBC3—esophageal cancer	0.00334	0.00547	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—BAX—esophageal cancer	0.00328	0.00539	CbGpPWpGaD
Calcitriol—Psoriasis—Methotrexate—esophageal cancer	0.00326	0.0139	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00324	0.00532	CbGpPWpGaD
Calcitriol—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00323	0.00531	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTO1—esophageal cancer	0.00322	0.00529	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00318	0.00521	CbGpPWpGaD
Calcitriol—Polyuria—Cisplatin—esophageal cancer	0.00309	0.0132	CcSEcCtD
Calcitriol—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00298	0.00489	CbGpPWpGaD
Calcitriol—Nocturia—Capecitabine—esophageal cancer	0.00297	0.0127	CcSEcCtD
Calcitriol—Bone pain—Capecitabine—esophageal cancer	0.00287	0.0123	CcSEcCtD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00286	0.0047	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—esophageal cancer	0.00286	0.00469	CbGpPWpGaD
Calcitriol—CYP3A4—digestive system—esophageal cancer	0.00284	0.0182	CbGeAlD
Calcitriol—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00275	0.0118	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—SFN—esophageal cancer	0.00275	0.00451	CbGpPWpGaD
Calcitriol—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.00274	0.00449	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—ALDH2—esophageal cancer	0.00263	0.00431	CbGpPWpGaD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00255	0.00419	CbGpPWpGaD
Calcitriol—Blood creatinine increased—Cisplatin—esophageal cancer	0.00254	0.0109	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—EP300—esophageal cancer	0.00253	0.00415	CbGpPWpGaD
Calcitriol—Dehydration—Cisplatin—esophageal cancer	0.00252	0.0108	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.00251	0.00412	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTT1—esophageal cancer	0.0025	0.0041	CbGpPWpGaD
Calcitriol—Urine output increased—Capecitabine—esophageal cancer	0.00249	0.0106	CcSEcCtD
Calcitriol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00248	0.00406	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—CYP2A6—esophageal cancer	0.00247	0.00405	CbGpPWpGaD
Calcitriol—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00244	0.0104	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00243	0.00399	CbGpPWpGaD
Calcitriol—Nasopharyngitis—Cisplatin—esophageal cancer	0.00242	0.0104	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—PTGS1—esophageal cancer	0.00234	0.00384	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.0023	0.00982	CcSEcCtD
Calcitriol—Pancreatitis—Cisplatin—esophageal cancer	0.0023	0.00982	CcSEcCtD
Calcitriol—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00228	0.00374	CbGpPWpGaD
Calcitriol—Polyuria—Capecitabine—esophageal cancer	0.00228	0.00972	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—esophageal cancer	0.00227	0.00372	CbGpPWpGaD
Calcitriol—Libido decreased—Capecitabine—esophageal cancer	0.00216	0.00921	CcSEcCtD
Calcitriol—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00214	0.00352	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00212	0.00348	CbGpPWpGaD
Calcitriol—Thirst—Capecitabine—esophageal cancer	0.0021	0.00897	CcSEcCtD
Calcitriol—Dermatitis bullous—Capecitabine—esophageal cancer	0.00209	0.00893	CcSEcCtD
Calcitriol—Conjunctivitis—Cisplatin—esophageal cancer	0.00203	0.00868	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—esophageal cancer	0.00203	0.00333	CbGpPWpGaD
Calcitriol—Pain in extremity—Capecitabine—esophageal cancer	0.002	0.00854	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP1B1—esophageal cancer	0.00199	0.00327	CbGpPWpGaD
Calcitriol—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00198	0.00847	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00196	0.00322	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00192	0.00315	CbGpPWpGaD
Calcitriol—GC—Metabolism—SLC52A3—esophageal cancer	0.00188	0.00309	CbGpPWpGaD
Calcitriol—GC—Metabolism—BLVRB—esophageal cancer	0.00188	0.00309	CbGpPWpGaD
Calcitriol—Blood creatinine increased—Capecitabine—esophageal cancer	0.00187	0.008	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP19A1—esophageal cancer	0.00187	0.00307	CbGpPWpGaD
Calcitriol—Dehydration—Capecitabine—esophageal cancer	0.00186	0.00794	CcSEcCtD
Calcitriol—Urine output increased—Methotrexate—esophageal cancer	0.00185	0.00792	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00185	0.00303	CbGpPWpGaD
Calcitriol—Abdominal pain upper—Capecitabine—esophageal cancer	0.00183	0.0078	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.0018	0.00769	CcSEcCtD
Calcitriol—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00179	0.00294	CbGpPWpGaD
Calcitriol—Nasopharyngitis—Capecitabine—esophageal cancer	0.00179	0.00764	CcSEcCtD
Calcitriol—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00172	0.00283	CbGpPWpGaD
Calcitriol—Polyuria—Methotrexate—esophageal cancer	0.00169	0.00724	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00168	0.00276	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00168	0.00275	CbGpPWpGaD
Calcitriol—Arrhythmia—Cisplatin—esophageal cancer	0.00168	0.00716	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—esophageal cancer	0.00166	0.00272	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00164	0.0027	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00164	0.0027	CbGpPWpGaD
Calcitriol—Erythema—Cisplatin—esophageal cancer	0.00163	0.00698	CcSEcCtD
Calcitriol—GC—Metabolism—SLC10A2—esophageal cancer	0.0016	0.00263	CbGpPWpGaD
Calcitriol—GC—Metabolism—CA1—esophageal cancer	0.0016	0.00263	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—EP300—esophageal cancer	0.00158	0.00259	CbGpPWpGaD
Calcitriol—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00157	0.00258	CbGpPWpGaD
Calcitriol—Weight decreased—Capecitabine—esophageal cancer	0.00156	0.00668	CcSEcCtD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00154	0.00253	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—BAX—esophageal cancer	0.00153	0.00251	CbGpPWpGaD
Calcitriol—Conjunctivitis—Capecitabine—esophageal cancer	0.0015	0.0064	CcSEcCtD
Calcitriol—Urinary tract infection—Capecitabine—esophageal cancer	0.0015	0.0064	CcSEcCtD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00147	0.00241	CbGpPWpGaD
Calcitriol—GC—Metabolism—CA2—esophageal cancer	0.00146	0.0024	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00143	0.00235	CbGpPWpGaD
Calcitriol—Convulsion—Cisplatin—esophageal cancer	0.00141	0.00604	CcSEcCtD
Calcitriol—Myalgia—Cisplatin—esophageal cancer	0.00139	0.00594	CcSEcCtD
Calcitriol—Haemoglobin—Capecitabine—esophageal cancer	0.00139	0.00594	CcSEcCtD
Calcitriol—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00139	0.00228	CbGpPWpGaD
Calcitriol—Anxiety—Cisplatin—esophageal cancer	0.00139	0.00592	CcSEcCtD
Calcitriol—Haemorrhage—Capecitabine—esophageal cancer	0.00138	0.00591	CcSEcCtD
Calcitriol—Discomfort—Cisplatin—esophageal cancer	0.00137	0.00587	CcSEcCtD
Calcitriol—GC—Metabolism—PLCE1—esophageal cancer	0.00136	0.00223	CbGpPWpGaD
Calcitriol—GC—Metabolism—ADH7—esophageal cancer	0.00136	0.00223	CbGpPWpGaD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00135	0.00222	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00135	0.00221	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Cisplatin—esophageal cancer	0.00133	0.00569	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00133	0.00218	CbGpPWpGaD
Calcitriol—Erythema multiforme—Capecitabine—esophageal cancer	0.00131	0.00559	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.0013	0.00213	CbGpPWpGaD
Calcitriol—Skin disorder—Cisplatin—esophageal cancer	0.00129	0.00553	CcSEcCtD
Calcitriol—Anorexia—Cisplatin—esophageal cancer	0.00127	0.00543	CcSEcCtD
Calcitriol—Pancreatitis—Methotrexate—esophageal cancer	0.00126	0.00539	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—esophageal cancer	0.00124	0.00203	CbGpPWpGaD
Calcitriol—Arrhythmia—Capecitabine—esophageal cancer	0.00124	0.00528	CcSEcCtD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00123	0.00202	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00121	0.00519	CcSEcCtD
Calcitriol—Erythema—Capecitabine—esophageal cancer	0.0012	0.00514	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.0012	0.00197	CbGpPWpGaD
Calcitriol—GC—Metabolism—ADH1B—esophageal cancer	0.00119	0.00196	CbGpPWpGaD
Calcitriol—Dysgeusia—Capecitabine—esophageal cancer	0.00118	0.00504	CcSEcCtD
Calcitriol—Decreased appetite—Cisplatin—esophageal cancer	0.00116	0.00495	CcSEcCtD
Calcitriol—Drowsiness—Methotrexate—esophageal cancer	0.00115	0.0049	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.00114	0.00187	CbGpPWpGaD
Calcitriol—GC—Metabolism—TYMP—esophageal cancer	0.00114	0.00187	CbGpPWpGaD
Calcitriol—Pain—Cisplatin—esophageal cancer	0.00114	0.00487	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00113	0.00186	CbGpPWpGaD
Calcitriol—Conjunctivitis—Methotrexate—esophageal cancer	0.00111	0.00476	CcSEcCtD
Calcitriol—GC—Metabolism—CYP26A1—esophageal cancer	0.00111	0.00182	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—CREBBP—esophageal cancer	0.00108	0.00178	CbGpPWpGaD
Calcitriol—GC—Metabolism—ALOX15—esophageal cancer	0.00108	0.00177	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—RB1—esophageal cancer	0.00108	0.00177	CbGpPWpGaD
Calcitriol—Body temperature increased—Cisplatin—esophageal cancer	0.00105	0.0045	CcSEcCtD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00104	0.00171	CbGpPWpGaD
Calcitriol—Hypertension—Capecitabine—esophageal cancer	0.00104	0.00444	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00104	0.0017	CbGpPWpGaD
Calcitriol—Haemoglobin—Methotrexate—esophageal cancer	0.00103	0.00442	CcSEcCtD
Calcitriol—GC—Metabolism—TPI1—esophageal cancer	0.00103	0.00169	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTO1—esophageal cancer	0.00103	0.00169	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00103	0.00169	CbGpPWpGaD
Calcitriol—Haemorrhage—Methotrexate—esophageal cancer	0.00103	0.0044	CcSEcCtD
Calcitriol—Chest pain—Capecitabine—esophageal cancer	0.00102	0.00438	CcSEcCtD
Calcitriol—Myalgia—Capecitabine—esophageal cancer	0.00102	0.00438	CcSEcCtD
Calcitriol—Anxiety—Capecitabine—esophageal cancer	0.00102	0.00436	CcSEcCtD
Calcitriol—Discomfort—Capecitabine—esophageal cancer	0.00101	0.00433	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—SLC52A3—esophageal cancer	0.00101	0.00165	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—BLVRB—esophageal cancer	0.00101	0.00165	CbGpPWpGaD
Calcitriol—Dry mouth—Capecitabine—esophageal cancer	0.001	0.00428	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000995	0.00163	CbGpPWpGaD
Calcitriol—GC—Metabolism—ALDOB—esophageal cancer	0.000989	0.00162	CbGpPWpGaD
Calcitriol—Hypersensitivity—Cisplatin—esophageal cancer	0.000982	0.00419	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000979	0.00161	CbGpPWpGaD
Calcitriol—Erythema multiforme—Methotrexate—esophageal cancer	0.000973	0.00416	CcSEcCtD
Calcitriol—Asthenia—Cisplatin—esophageal cancer	0.000956	0.00408	CcSEcCtD
Calcitriol—Skin disorder—Capecitabine—esophageal cancer	0.000954	0.00408	CcSEcCtD
Calcitriol—GC—Metabolism—GAPDH—esophageal cancer	0.000952	0.00156	CbGpPWpGaD
Calcitriol—GC—Metabolism—CRABP1—esophageal cancer	0.000944	0.00155	CbGpPWpGaD
Calcitriol—Anorexia—Capecitabine—esophageal cancer	0.000936	0.004	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—BCL2—esophageal cancer	0.000933	0.00153	CbGpPWpGaD
Calcitriol—Diarrhoea—Cisplatin—esophageal cancer	0.000912	0.0039	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00091	0.00149	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000899	0.00147	CbGpPWpGaD
Calcitriol—GC—Metabolism—GNG7—esophageal cancer	0.000897	0.00147	CbGpPWpGaD
Calcitriol—Erythema—Methotrexate—esophageal cancer	0.000896	0.00383	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000895	0.00382	CcSEcCtD
Calcitriol—Insomnia—Capecitabine—esophageal cancer	0.000889	0.0038	CcSEcCtD
Calcitriol—Dysgeusia—Methotrexate—esophageal cancer	0.000877	0.00375	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—SLC10A2—esophageal cancer	0.000855	0.0014	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CA1—esophageal cancer	0.000855	0.0014	CbGpPWpGaD
Calcitriol—Decreased appetite—Capecitabine—esophageal cancer	0.000854	0.00365	CcSEcCtD
Calcitriol—Vomiting—Cisplatin—esophageal cancer	0.000847	0.00362	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000846	0.00139	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SMG6—esophageal cancer	0.000843	0.00138	CbGpPWpGaD
Calcitriol—GC—Metabolism—ALDH2—esophageal cancer	0.000841	0.00138	CbGpPWpGaD
Calcitriol—Rash—Cisplatin—esophageal cancer	0.00084	0.00359	CcSEcCtD
Calcitriol—Constipation—Capecitabine—esophageal cancer	0.00084	0.00359	CcSEcCtD
Calcitriol—Pain—Capecitabine—esophageal cancer	0.00084	0.00359	CcSEcCtD
Calcitriol—Dermatitis—Cisplatin—esophageal cancer	0.00084	0.00359	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000833	0.00137	CbGpPWpGaD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000817	0.00134	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000803	0.00343	CcSEcCtD
Calcitriol—GC—Metabolism—GSTT1—esophageal cancer	0.0008	0.00131	CbGpPWpGaD
Calcitriol—Nausea—Cisplatin—esophageal cancer	0.000792	0.00338	CcSEcCtD
Calcitriol—GC—Metabolism—CYP2A6—esophageal cancer	0.000791	0.0013	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000788	0.00129	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CA2—esophageal cancer	0.000782	0.00128	CbGpPWpGaD
Calcitriol—Urticaria—Capecitabine—esophageal cancer	0.00078	0.00333	CcSEcCtD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000778	0.00128	CbGpPWpGaD
Calcitriol—Body temperature increased—Capecitabine—esophageal cancer	0.000777	0.00332	CcSEcCtD
Calcitriol—Abdominal pain—Capecitabine—esophageal cancer	0.000777	0.00332	CcSEcCtD
Calcitriol—Convulsion—Methotrexate—esophageal cancer	0.000776	0.00332	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CDKN1A—esophageal cancer	0.000775	0.00127	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000764	0.00125	CbGpPWpGaD
Calcitriol—Myalgia—Methotrexate—esophageal cancer	0.000763	0.00326	CcSEcCtD
Calcitriol—Chest pain—Methotrexate—esophageal cancer	0.000763	0.00326	CcSEcCtD
Calcitriol—Discomfort—Methotrexate—esophageal cancer	0.000754	0.00322	CcSEcCtD
Calcitriol—GC—Metabolism—PTGS1—esophageal cancer	0.00075	0.00123	CbGpPWpGaD
Calcitriol—GC—Metabolism—ENO1—esophageal cancer	0.00075	0.00123	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000747	0.00123	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000744	0.00122	CbGpPWpGaD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000742	0.00122	CbGpPWpGaD
Calcitriol—GC—Metabolism—PSME1—esophageal cancer	0.000739	0.00121	CbGpPWpGaD
Calcitriol—GC—Metabolism—PSME2—esophageal cancer	0.000739	0.00121	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—EP300—esophageal cancer	0.000737	0.00121	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000734	0.0012	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Methotrexate—esophageal cancer	0.000731	0.00312	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—PLCE1—esophageal cancer	0.000727	0.00119	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ADH7—esophageal cancer	0.000727	0.00119	CbGpPWpGaD
Calcitriol—Hypersensitivity—Capecitabine—esophageal cancer	0.000724	0.00309	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000718	0.00118	CbGpPWpGaD
Calcitriol—Skin disorder—Methotrexate—esophageal cancer	0.00071	0.00303	CcSEcCtD
Calcitriol—Asthenia—Capecitabine—esophageal cancer	0.000705	0.00301	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000697	0.00114	CbGpPWpGaD
Calcitriol—Anorexia—Methotrexate—esophageal cancer	0.000697	0.00298	CcSEcCtD
Calcitriol—Pruritus—Capecitabine—esophageal cancer	0.000695	0.00297	CcSEcCtD
Calcitriol—Diarrhoea—Capecitabine—esophageal cancer	0.000672	0.00287	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000666	0.00285	CcSEcCtD
Calcitriol—Insomnia—Methotrexate—esophageal cancer	0.000661	0.00283	CcSEcCtD
Calcitriol—Somnolence—Methotrexate—esophageal cancer	0.00065	0.00278	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000645	0.00106	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000641	0.00105	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NR1I2—esophageal cancer	0.000639	0.00105	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP1B1—esophageal cancer	0.000637	0.00105	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ADH1B—esophageal cancer	0.000637	0.00105	CbGpPWpGaD
Calcitriol—Decreased appetite—Methotrexate—esophageal cancer	0.000636	0.00272	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—EGFR—esophageal cancer	0.000628	0.00103	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000627	0.00103	CbGpPWpGaD
Calcitriol—Pain—Methotrexate—esophageal cancer	0.000625	0.00267	CcSEcCtD
Calcitriol—Vomiting—Capecitabine—esophageal cancer	0.000625	0.00267	CcSEcCtD
Calcitriol—Rash—Capecitabine—esophageal cancer	0.000619	0.00265	CcSEcCtD
Calcitriol—Dermatitis—Capecitabine—esophageal cancer	0.000619	0.00264	CcSEcCtD
Calcitriol—Headache—Capecitabine—esophageal cancer	0.000615	0.00263	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—TYMP—esophageal cancer	0.000609	0.001	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000603	0.00099	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.0006	0.000984	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP19A1—esophageal cancer	0.000599	0.000983	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000598	0.00255	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—CYP26A1—esophageal cancer	0.000593	0.000972	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000592	0.000971	CbGpPWpGaD
Calcitriol—Nausea—Capecitabine—esophageal cancer	0.000584	0.00249	CcSEcCtD
Calcitriol—Urticaria—Methotrexate—esophageal cancer	0.000581	0.00248	CcSEcCtD
Calcitriol—Abdominal pain—Methotrexate—esophageal cancer	0.000578	0.00247	CcSEcCtD
Calcitriol—Body temperature increased—Methotrexate—esophageal cancer	0.000578	0.00247	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—ALOX15—esophageal cancer	0.000577	0.000948	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000572	0.000938	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000564	0.000925	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000556	0.000913	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000552	0.000905	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTO1—esophageal cancer	0.000551	0.000904	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—TPI1—esophageal cancer	0.000551	0.000904	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—HIST1H2BM—esophageal cancer	0.000548	0.000899	CbGpPWpGaD
Calcitriol—GC—Metabolism—HMOX1—esophageal cancer	0.000547	0.000897	CbGpPWpGaD
Calcitriol—Hypersensitivity—Methotrexate—esophageal cancer	0.000539	0.0023	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000536	0.00088	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ALDOB—esophageal cancer	0.000528	0.000867	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP53—esophageal cancer	0.000527	0.000866	CbGpPWpGaD
Calcitriol—GC—Metabolism—ABCB1—esophageal cancer	0.000525	0.000861	CbGpPWpGaD
Calcitriol—Asthenia—Methotrexate—esophageal cancer	0.000525	0.00224	CcSEcCtD
Calcitriol—Pruritus—Methotrexate—esophageal cancer	0.000517	0.00221	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GAPDH—esophageal cancer	0.000508	0.000834	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CRABP1—esophageal cancer	0.000504	0.000827	CbGpPWpGaD
Calcitriol—Diarrhoea—Methotrexate—esophageal cancer	0.0005	0.00214	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000486	0.000798	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000484	0.000794	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GNG7—esophageal cancer	0.000479	0.000786	CbGpPWpGaD
Calcitriol—Vomiting—Methotrexate—esophageal cancer	0.000465	0.00199	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000462	0.000759	CbGpPWpGaD
Calcitriol—Rash—Methotrexate—esophageal cancer	0.000461	0.00197	CcSEcCtD
Calcitriol—Dermatitis—Methotrexate—esophageal cancer	0.000461	0.00197	CcSEcCtD
Calcitriol—Headache—Methotrexate—esophageal cancer	0.000458	0.00196	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000457	0.00075	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00045	0.000738	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ALDH2—esophageal cancer	0.000449	0.000737	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000443	0.000728	CbGpPWpGaD
Calcitriol—Nausea—Methotrexate—esophageal cancer	0.000434	0.00186	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTT1—esophageal cancer	0.000427	0.000701	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PSME2—esophageal cancer	0.000425	0.000698	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PSME1—esophageal cancer	0.000425	0.000698	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP2A6—esophageal cancer	0.000422	0.000693	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000421	0.00069	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000419	0.000688	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000418	0.000686	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000412	0.000677	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH3—esophageal cancer	0.000401	0.000658	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ENO1—esophageal cancer	0.0004	0.000657	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS1—esophageal cancer	0.0004	0.000657	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000397	0.000651	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PSME1—esophageal cancer	0.000394	0.000647	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PSME2—esophageal cancer	0.000394	0.000647	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH2—esophageal cancer	0.00036	0.00059	CbGpPWpGaD
Calcitriol—GC—Metabolism—CREBBP—esophageal cancer	0.000351	0.000576	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000344	0.000565	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000341	0.000559	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP1B1—esophageal cancer	0.00034	0.000559	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000324	0.000532	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.00032	0.000526	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP19A1—esophageal cancer	0.00032	0.000525	CbGpPWpGaD
Calcitriol—GC—Metabolism—NOS3—esophageal cancer	0.000314	0.000515	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000304	0.000498	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SMAD4—esophageal cancer	0.000302	0.000496	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—HMOX1—esophageal cancer	0.000292	0.000479	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTGS2—esophageal cancer	0.000287	0.000471	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000286	0.00047	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ABCB1—esophageal cancer	0.00028	0.00046	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000258	0.000424	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000255	0.000418	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—esophageal cancer	0.000249	0.000408	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000243	0.000398	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000239	0.000393	CbGpPWpGaD
Calcitriol—GC—Metabolism—EP300—esophageal cancer	0.000239	0.000392	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH1—esophageal cancer	0.000223	0.000365	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000212	0.000348	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—CREBBP—esophageal cancer	0.000202	0.000331	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CREBBP—esophageal cancer	0.000187	0.000307	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—esophageal cancer	0.000177	0.00029	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NOS3—esophageal cancer	0.000168	0.000275	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS2—esophageal cancer	0.000153	0.000252	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.00013	0.000214	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.00013	0.000214	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—EP300—esophageal cancer	0.000128	0.000209	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—esophageal cancer	0.00012	0.000197	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000111	0.000182	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CA1—esophageal cancer	0.000111	0.000182	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CA2—esophageal cancer	0.000101	0.000167	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—esophageal cancer	9.44e-05	0.000155	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ADH7—esophageal cancer	9.43e-05	0.000155	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.43e-05	0.000155	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.27e-05	0.000136	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TYMP—esophageal cancer	7.9e-05	0.00013	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.69e-05	0.000126	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.49e-05	0.000123	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TPI1—esophageal cancer	7.15e-05	0.000117	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.15e-05	0.000117	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.85e-05	0.000112	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.6e-05	0.000108	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.54e-05	0.000107	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GNG7—esophageal cancer	6.22e-05	0.000102	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.83e-05	9.56e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.54e-05	9.1e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.48e-05	8.99e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ENO1—esophageal cancer	5.19e-05	8.52e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.19e-05	8.52e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PSME1—esophageal cancer	5.12e-05	8.4e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PSME2—esophageal cancer	5.12e-05	8.4e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.42e-05	7.25e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.15e-05	6.81e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.79e-05	6.22e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.64e-05	5.97e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.43e-05	3.99e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NOS3—esophageal cancer	2.18e-05	3.57e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.99e-05	3.27e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—EP300—esophageal cancer	1.66e-05	2.72e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.22e-05	2.01e-05	CbGpPWpGaD
